dual agonist tirzepatide is a first-in-class targeting both GIP and GLP-1 receptors, offering a powerful and synergistic approach to glycaemic control and weight management. By acting on multiple metabolic pathways, tirzepatide: Enhances hormone GLP Tirzepatide 10mg – Dual GIP/GLP-1
Pay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
























